Biotech Values

[biocqr]

Stanford update on CD47 clinical trial...

http://stemcell.stanford.edu/CD47/

the first human clinical trials of anti-CD47 antibody will take place at Stanford in mid-2014, if all goes well.

Researchers and staff at Stanford are continuing to work hard preparing the groundwork for the clinical trials of our anti-CD47 antibody as a cancer therapy. As often happens during the development of new therapies, various complexities have pushed back the planned start date of the clinical trials. Although we had hoped to begin clinical trials in the first half of this year, we were aware that “unforeseen delays could slow progress," and indeed we are now hoping that clinical trials will begin in the summer or early fall 2014.